Saturday 7 November 2026
Export HCA’s income statement to Excel — free account
HCA Healthcare, Inc.
HCA Healthcare Medical Care Facilities
HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024.
- Revenue
- +3.59%
- EPS
- +23.8%
- Free cash flow
- −0.77%
- Total debt
- +13.4%
Quarter to September 2026, against a year earlier
496.04
11.44
−2.25%
Follow HCA
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
16.45 | 16.27 | 13.05 | 13.54 |
P/S ratio |
1.46 | 1.39 | 1.10 | 1.16 | |
P/FCF ratio |
14.35 | 13.35 | 14.34 | 15.33 | |
P/Operating CF |
46.79 | 52.54 | 36.82 | 20.53 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.06 | 2.00 | 1.73 | 1.79 | |
EV/EBITDA |
9.98 | 9.75 | 8.50 | 8.87 | |
EV/Operating CF |
12.33 | 11.76 | 12.11 | 12.64 | |
EV/FCF |
20.26 | 19.29 | 22.46 | 23.63 | |
Quick Ratio |
0.73 | 0.64 | 0.77 | 0.63 | |
Current Ratio |
0.97 | 0.83 | 0.99 | 0.82 | |
Net Debt/EBITDA |
11.02 | 12.35 | 12.06 | 12.62 | |
Debt/Assets |
76.57% | 78.15% | 78.61% | 79.58% | |
Debt/Equity |
(16.78) | (16.13) | (15.49) | (10.98) | |
Asset Turnover |
1.26 | 1.26 | 1.27 | 1.28 | |
Operating CF/Net income |
1.26 | 1.24 | 1.37 | 2.83 | |
Capex/Depreciation |
(1.61) | (1.19) | (1.29) | (1.41) | |
Interest Coverage |
5.60 | 4.92 | 5.15 | 4.88 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
42.84% | 43.35% | 40.98% | 43.23% | |
Intangible Assets out of Total Assets |
0.17 | 0.17 | 0.17 | 0.18 | |
Share Based Compensation of Revenue |
0.51% | 0.45% | 0.42% | 0.67% | |
Graham Net Nets |
(0.43) | (0.46) | (0.57) | (0.57) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
6.08% | 6.14% | 7.66% | 7.39% | |
Free Cash Flow Yield |
6.97% | 7.49% | 6.97% | 6.52% | |
Revenue per Share |
82.54 | 85.47 | 91.73 | 92.50 | |
Operating CF per Share |
9.98 | 9.01 | 10.59 | 20.79 | |
Capex per Share |
(6.30) | (5.00) | (5.58) | (6.32) | |
Free Cash Flow per Share |
3.68 | 4.00 | 5.01 | 14.46 | |
Cash per Share |
4.40 | 4.20 | 4.59 | 4.23 | |
Shareholders Equity per Share |
(11.72) | (13.32) | (14.55) | (21.43) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(11.72) | (13.32) | (14.55) | (21.43) | |
Free Cash Flow |
870.00 | 895.00 | 1,104.00 | 3,104.00 | |
Working Capital |
(567.00) | (3,206.00) | (122.00) | (3,560.00) | |
Capital Expenditures |
(1,489.00) | (1,119.00) | (1,231.00) | (1,357.00) | |
Net Current Asset Value |
(47,708.00) | (48,376.00) | (49,269.00) | (51,832.00) | |
EV/EBIT |
12.94 | 12.70 | 11.10 | 11.64 | |
Capex to Sales |
0.08 | 0.06 | 0.06 | 0.07 | |
Price to Operating Income |
9.16 | 8.79 | 7.08 | 7.55 | |
| Other line items | |||||
Average Receivables |
10,809.00 | 11,206.00 | 11,370.00 | 10,968.50 | |
Average Payables |
4,467.50 | 4,647.00 | 4,501.00 | 4,827.50 | |
Average Inventory |
1,695.00 | 1,737.50 | 1,727.00 | 1,702.00 | |
Average Assets |
60,116.50 | 60,624.00 | 61,393.00 | 61,599.50 | |
Average Common Equity |
(1,108.00) | (1,708.00) | (2,223.50) | (3,379.00) |
Columns are period end dates · fundamentals updated 2 Nov 2026